ARCHIVES

SEC Investigating Bristol-Myers’ Sales Statements

This article is from The Cancer Letter archive.

Vol. 28 No. 28 | July 12, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

In Brief: Cooper Says HEW May Stop Taking New Construction grants; Cancer Act Does Not Give Him That Right

May 2, 1975

Capizzi Succeeds Spurr as Director Of Bowman Gray Cancer Center

September 10, 1982